We describe the molecular study in a cohort of 120 Portuguese patients with the clinical diagnosis of Gilbert syndrome and in one with the diagnosis of Crigler-Najjar syndrome type II, as well as a prenatal diagnosis of Crigler-Najjar syndrome type I. Among the 120 unrelated patients with Gilbert syndrome, 110 were homozygous for the [TA]7 allele ([TA]7/[TA]7), and one patient was a compound heterozygote for two different insertions ([TA]7/[TA]8). The remaining 9 patients were heterozygous for the TA insertion ([TA]6/[TA]7). Additional studies in these 9 patients revealed heterozygosity for the c.674T>G, c.488_491dupACCT and c.923G>A mutations, in 1, 1 and 4 patients, respectively. The patient with Crigler-Najjar syndrome type II was a compound heterozygote for [TA]7 and the c.923G>A mutation. The undocumented polymorphisms c.-1126C>T and c.997-82T>C were also detected in the course of this study. Prenatal diagnosis in a family with a boy previously diagnosed as Crigler-Najjar syndrome type I and homozygosity for the c.923G>A mutation revealed that the fetus was unaffected. Homozygosity for the [TA] insertion was found to be the most frequent cause of GS in our population. Identification of further mutations in the UGT1A1 gene was also seen to contribute significantly towards diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2005.09.002DOI Listing

Publication Analysis

Top Keywords

crigler-najjar syndrome
16
syndrome type
16
portuguese patients
8
patients clinical
8
clinical diagnosis
8
diagnosis gilbert
8
gilbert syndrome
8
diagnosis crigler-najjar
8
prenatal diagnosis
8
compound heterozygote
8

Similar Publications

Crigler-Najjar syndrome is an ultra-rare monogenic recessive liver disease caused by gene mutations. Complete UGT1A1 deficiency results in severe unconjugated hyperbilirubinemia in newborns that, if not treated, may lead to brain damage and death. Treatment is based on intensive phototherapy, but its efficacy decreases with age, rendering liver transplantation the only curative option.

View Article and Find Full Text PDF

Therapeutic Options for Crigler-Najjar Syndrome: A Scoping Review.

Int J Mol Sci

October 2024

Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

Article Synopsis
  • Crigler-Najjar Syndrome (CNS) is a rare genetic disorder that leads to severe jaundice due to impaired processing of bilirubin, with two forms: CNS type 1 (more severe) and CNS type 2 (milder).
  • The management of CNS1 is aggressive, often requiring liver transplantation as the only definitive treatment, while CNS2 can be managed with medications like phenobarbital.
  • New therapies, including gene therapy and autologous hepatocyte transplantation, are emerging as potential alternatives to surgery, aiming to enhance treatment effectiveness and improve life quality for CNS patients.
View Article and Find Full Text PDF

Analysis of UGT1A1 genotype-phenotype correlation in Chinese patients with gilbert and crigler-Najjar II syndrome.

Eur J Med Genet

October 2024

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. Electronic address:

Article Synopsis
  • The study examined UGT1A1 gene variants in 310 Chinese patients with Gilbert syndrome (GS) and Crigler-Najjar syndrome (CNS-II) to understand genotype-phenotype correlations.
  • A total of 21 different UGT1A1 variants were identified, including nine that were previously unknown, with a distinct variant pattern compared to Western populations.
  • The research found significant differences in serum total bilirubin and triglyceride levels among various genotypes, indicating how specific UGT1A1 variants affect clinical outcomes in patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!